MENU
Harrow (HROW) Ownership - Who owns Harrow?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
467.85M
P/E Ratio
39.53
Total Cash
82.77M
Projected Growth
N/A
Total Debt
190.5M
Revenue
130.19M
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash/Share
2.34
Total Debt/Equity
N/A
Revenue/Share
3.99 USD as % of share price
Fundamentals
HROW
Capitalization
468M
P/E Ratio
39.53
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash
82.8M
Total Cash/Share
2.34
Total Debt
191M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.99%
Revenue
130M
ROE
N/A
Book Value
70.8M
P/B Ratio
6.40
Cash Flow
N/A
Earnings
-0.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
35K
Current Ratio
2.83
Current Revenue Per Employee
167534.56
Dividends Per Share - Security
N/A
EBITDA
9.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.91
Revenue To Assets
-10.40
Shares Held By Institutions
343M
Shares Outstanding - Current
35.4M
Total Liabilities
242M
Total Volume MTD
N/A
Value
-1
Gain YTD
257.589
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a pharmaceutical company
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com